Glucosamine synthase producing bacterium based on CRISPR-Cas9 technology and construction method and application of glucosamine synthase producing bacterium
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- YANGZHOU RIXING BIO TECH
- Publication Date
- 2019-10-29
- Estimated Expiration
- Not applicable · inactive patent
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to the technical field of gene knockout, in particular to a CRISPR-Cas9 technology-based ammonia sugar synthase-producing bacterium, a construction method and an application thereof. Background technique
[0002] Glucosamine (GlcN) has a good curative effect in the prevention and treatment of arthritis. Arthritis is mainly caused by joint damage and abnormal articular cartilage, which causes inconvenience to patients in daily activities and even leads to loss of bone and joint function. , Glucosamine stimulates chondrocytes through a certain mechanism in the body, effectively promotes the synthesis of collagen, and gradually repairs damaged articular cartilage. Glucosamine supplementation can promote the synthesis of glycoproteins to repair damaged cartilage, increase the lubrication between joints, and reduce the wear and tear between joints. In addition, glucosamine can also regulate the body's endocrine and adsorb on the intes...